Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jose-Ignacio Garcia-Bolao, PhD, FESC
Clinica Universidad de Navarra
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
139 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Peninsula Health
Frankston, Victoria, Australia
- Barwon Health Myers House Ground Floor Geelong Hospital
Geelong, Victoria, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Landeskrankenhaus Salzburg Universitätsklinikum Der Pmu
Salzburg, Austria
- Allgemeines Krankenhaus Der Stadt Wien, Univ.Klinik Für Innere Medizin Ii
Vienna, Austria
- Krankenhaus Nord
Vienna, Austria
- Virga Jesse Ziekenhuis
Hasselt, Belgium
- Ucl de Mont Godinne
Yvoir, Belgium
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Fleurimont Hospital (chu de Sherbrooke)
Sherbrooke, Quebec, Canada
- Royal Alexandra Hospital - Cardiology Research Ck Hui Heart Centre
Edmonton, Canada
- Hôpital Du Sacré-Cœur de Montréal
Montreal, Canada
- Faculty Hospital U Sv Anny
Brno, Czechia
- Kardiologicke Centrum Agel
Pardubice, Czechia
- Ikem - Institut Klinicke A Experimentalni Mediciny
Prague, Czechia
- Centre Hospitalier de la Cote Basque
Bayonne, France
- Chu de Besancon
Besançon, France
- Chu Brest - Hopital Cavale Blanche
Brest, France
- Ch de Cannes
Cannes, France
- Aphp Chu Henri Mondor
Créteil, France
- Chu Dijon
Dijon, France
- Hopital Privé de Clairval
Marseille, France
- Hospital Prive Jacques Cartier
Massy, France
- Ch Annecy Genevois
Metz-Tessy, France
- Clinique Du Millénaire
Montpellier, France
- Ncn Nouvelles Cliniques Nantaises
Nantes, France
- Chu Nimes Cedex
Nîmes, France
- Chru Orleans
Orléans, France
- Chg de Pau
Pau, France
- Chu de Poitiers
Poitiers, France
- Chu Amiens Hopital Sud
Salouël, France
- Clinique Pasteur
Toulouse, France
- Chu Tours - Hospital Trousseau
Tours, France
- Clinique Saint Gatien
Tours, France
- Ch Belfort Montbeliard
Trévenans, France
- Hôpital Nord Franche-Comté
Trévenans, France
- Centre Hospitalier de Valence
Valence, France
- Charite Universitätsmedizin Berlin Cbf
Berlin, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Apr 2017
- Primary completion
- 15 Nov 2021
- Completion
- 15 Nov 2021
- Last update posted
- 25 Oct 2023
- Registered enrollment
- 2,044
- Registry id
- NCT03075215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.